Possible additional antidepressant-like mechanism of sodium butyrate: Targeting the hippocampus

Neuropharmacology

Volumn 81, Issue , 2014, Pages 292-302

  Han, Arum ^a   Sung, Yu Bin ^a   Chung, Soo Young ^b   Kwon, Min Soo ^a  

^a CHA University   (South Korea)

^b DIRAMS   (South Korea)

Author keywords

BDNF; CREB; Depression; Hippocampus; Histone acetylation; Sodium butyrate

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BUTYRIC ACID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE H3; MESSENGER RNA; ANTIDEPRESSANT AGENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HISTONE DEACETYLASE; SUCROSE; SWEETENING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CHRONIC RESTRAINT STRESS; CONTROLLED STUDY; DEPRESSION; EXPERIMENTAL BEHAVIORAL TEST; FORCED SWIM TEST; HIPPOCAMPAL CA1 REGION; HISTOLOGY; HISTONE ACETYLATION; IMMOBILIZATION STRESS; IMMUNOHISTOCHEMISTRY; LIGHT DARK TEST; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SUCROSE PREFERENCE TEST; TAIL SUSPENSION TEST; WESTERN BLOTTING; ANIMAL; COMPLICATION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; FOOD PREFERENCE; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; IMMOBILIZATION; INSTITUTE FOR CANCER RESEARCH MOUSE; MENTAL STRESS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; SWIMMING; VISUAL ADAPTATION;

ADAPTATION, OCULAR; ANIMALS; ANTIDEPRESSIVE AGENTS; BUTYRIC ACID; CREB-BINDING PROTEIN; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD PREFERENCES; GENE EXPRESSION REGULATION; HINDLIMB SUSPENSION; HIPPOCAMPUS; HISTONE DEACETYLASES; MALE; MICE; MICE, INBRED ICR; STRESS, PSYCHOLOGICAL; SUCROSE; SWEETENING AGENTS; SWIMMING;

EID: 84896529057     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.02.017     Document Type: Article

References (54)

1. O. Berton, C.A. McClung, R.J. Dileone, V. Krishnan, W. Renthal, S.J. Russo, D. Graham, N.M. Tsankova, C.A. Bolanos, M. Rios, L.M. Monteggia, D.W. Self, and E.J. Nestler Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress Science 311 2006 864 868
2. A. Bonni, A. Brunet, A.E. West, S.R. Datta, M.A. Takasu, and M.E. Greenberg Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms Science 286 1999 1358 1362
3. J.A. Bouwknecht, J. van der Gugten, L. Groenink, B. Olivier, and R.E. Paylor Behavioral and physiological mouse models for anxiety: effects of flesinoxan in 129S6/SvEvTac and C57BL/6J mice Eur. J. Pharmacol. 494 2004 45 53
4. R.S. Broide, J.M. Redwine, N. Aftahi, W. Young, F.E. Bloom, and C.J. Winrow Distribution of histone deacetylases 1-11 in the rat brain J. Mol. Neurosci. 31 2007 47 58
5. N. Carey, and N.B. La Thangue Histone deacetylase inhibitors: gathering pace Curr. Opin. Pharmacol. 6 2006 369 375
6. A.C. Chen, Y. Shirayama, K.H. Shin, R.L. Neve, and R.S. Duman Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect Biol. Psychiatry 49 2001 753 762
7. A.C. Conti, J.F. Cryan, A. Dalvi, I. Lucki, and J.A. Blendy cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs J. Neurosci. 22 2002 3262 3268
8. H.E. Covington, I. Maze, Q.C. LaPlant, V.F. Vialou, Y.N. Ohnishi, O. Berton, D.M. Fass, W. Renthal, A.J. Rush, E.Y. Wu, S. Ghose, V. Krishnan, S.J. Russo, C. Tamminga, S.J. Haggarty, and E.J. Nestler Antidepressant actions of histone deacetylase inhibitors J. Neurosci. 29 2009 11451 11460
9. I. Covington, E. Herbert, V.F. Vialou, Q. LaPlant, Y.N. Ohnishi, and E.J. Nestler Hippocampal-dependent antidepressant-like activity of histone deacetylase inhibition Neurosci. Lett. 493 2011 122 126
10. J. Crawley, and F.K. Goodwin Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines Pharmacol. Biochem. Behav. 13 1980 167 170
11. J.R. Davie Inhibition of histone deacetylase activity by butyrate J. Nutr. 133 2003 2485S 2493S
12. R.S. Duman, J. Malberg, S. Nakagawa, and C. D'Sa Neuronal plasticity and survival in mood disorders Biol. Psychiatry 48 2000 732 739
13. R.S. Duman, and L.M. Monteggia A neurotrophic model for stress-related mood disorders Biol. Psychiatry 59 2006 1116 1127
14. G. Felsenfeld, and M. Groudine Controlling the double helix Nature 421 2003 448 453
15. M.S. Finnin, J.R. Donigian, A. Cohen, V.M. Richon, R.A. Rifkind, P.A. Marks, R. Breslow, and N.P. Pavletich Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors Nature 401 1999 188 193
16. K.B.J.P.G. Franklin The Mouse Brain in Sterotaxic Coordinates 1997 Academic Press San Diego
17. R.H. Goodman, and S. Smolik CBP/p300 in cell growth, transformation, and development Genes Dev. 14 2000 1553 1577
18. M. Gottlicher, S. Minucci, P. Zhu, O.H. Kramer, A. Schimpf, S. Giavara, J.P. Sleeman, F. Lo Coco, C. Nervi, P.G. Pelicci, and T. Heinzel Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells EMBO J. 20 2001 6969 6978
19. J. Grønli, C. Bramham, R. Murison, T. Kanhema, E. Fiske, B. Bjorvatn, R. Ursin, and C.M. Portas Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper Pharmacol. Biochem. Behav. 85 2006 842 849
20. B.B. Gundersen, and J.A. Blendy Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety Neuropharmacology 57 2009 67 74
21. J.P. Herman, and W.E. Cullinan Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis Trends Neurosci. 20 1997 78 84
22. F. Hollis, F. Duclot, A. Gunjan, and M. Kabbaj Individual differences in the effect of social defeat on anhedonia and histone acetylation in the rat hippocampus Horm Behav. 59 2011 331 337
23. T. Jenuwein, and C.D. Allis Translating the histone code Science 293 2001 1074 1080
24. E. Kalkhoven CBP and p300: HATs for different occasions Biochem. Pharmacol. 68 2004 1145 1155
25. R.C. Kessler, P. Berglund, O. Demler, R. Jin, K.R. Merikangas, and E.E. Walters Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication Arch. Gen. Psychiatry 62 2005 593 602
26. K.-S. Kim, and P.-L. Han Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters J. Neurosci. Res. 83 2006 497 507
27. E. Korzus, M.G. Rosenfeld, and M. Mayford CBP histone acetyltransferase activity is a critical component of memory consolidation Neuron 42 2004 961 972
28. V. Krishnan, and E.J. Nestler The molecular neurobiology of depression Nature 455 2008 894 902
29. M.-S. Kwon, Y.-J. Seo, S.-M. Choi, H.-W. Choi, J.-S. Jung, S.-H. Park, and H.-W. Suh The differential effects of single or repeated restraint stress on kainic acid-induced neuronal death in the hippocampal CA3 region: the role of glucocorticoid and various signal molecules J. Neurochem. 103 2007 1530 1541
30. M.S. Kwon, Y.J. Seo, E.J. Shim, J.K. Lee, J.E. Jang, S.H. Park, J.S. Jung, and H.W. Suh The differential effects of emotional or physical stress on pain behaviors or on c-Fos immunoreactivity in paraventricular nucleus or arcuate nucleus Brain Res. 1190 2008 122 131
31. S. Lee, J. Jeong, Y. Kwak, and S.K. Park Depression research: where are we now? Mol. Brain 3 2010 8
32. G.R. Lewin, and Y.-A. Barde Physiology of the neurotrophins Annu. Rev. Neurosci. 19 1996 289 317
33. H. Lin, X. Geng, W. Dang, B. Wu, Z. Dai, Y. Li, Y. Yang, H. Zhang, and J. Shi Molecular mechanisms associated with the antidepressant effects of the class I histone deacetylase inhibitor MS-275 in the rat ventrolateral orbital cortex Brain Res. 1447 2012 119 125
34. D. Ma, M. Hossain, G.K. Pettet, Y. Luo, T. Lim, S. Akimov, R.D. Sanders, N.P. Franks, and M. Maze Xenon preconditioning reduces brain damage from neonatal asphyxia in rats J. Cereb. Blood Flow Metab. 26 2006 199 208
35. J. Mill, and A. Petronis Molecular studies of major depressive disorder: the epigenetic perspective Mol. Psychiatry 12 2007 799 814
36. M. Minamiyama, M. Katsuno, H. Adachi, M. Waza, C. Sang, Y. Kobayashi, F. Tanaka, M. Doyu, A. Inukai, and G. Sobue Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy Hum. Mol. Genet. 13 2004 1183 1192
37. L.M. Monteggia, B. Luikart, M. Barrot, D. Theobold, I. Malkovska, S. Nef, L.F. Parada, and E.J. Nestler Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors Biol. Psychiatry 61 2007 187 197
38. E.J. Nestler, M. Barrot, R.J. Dileone, A.J. Eisch, S.J. Gold, and L.M. Monteggia Neurobiology of depression Neuron 34 2002 13 25
39. M. Nibuya, E.J. Nestler, and R.S. Duman Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus J. Neurosci. Off. J. Soc. Neurosci. 16 1996 2365 2372
40. A. Papadopoulos, Y. Chandramohan, A. Collins, S.K. Droste, D.J. Nutt, and J.M.H.M. Reul GABAergic control of novelty stress-responsive epigenetic and gene expression mechanisms in the rat dentate gyrus Eur. Neuropsychopharmacol. 21 2011 316 324
41. R.D. Porsolt, M. Le Pichon, and M. Jalfre Depression: a new animal model sensitive to antidepressant treatments Nature 266 1977 730 732
42. W.S. Rasband ImageJ 2008 http://rsbweb.nih.gov/ij/
43. A.M. Rasmusson, L. Shi, and R. Duman Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock Neuropsychopharmacology 27 2002 133 142
44. J.M.H.M. Reul, and Y. Chandramohan Epigenetic mechanisms in stress-related memory formation Psychoneuroendocrinology 32 Suppl. 1 2007 S21 S25
45. F.A. Schroeder, C.L. Lin, W.E. Crusio, and S. Akbarian Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse Biol. Psychiatry 62 2007 55 64
46. A.J. Shaywitz, and M.E. Greenberg CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals Annu. Rev. Biochem. 68 1999 821 861
47. Y. Shirayama, A.C. Chen, S. Nakagawa, D.S. Russell, and R.S. Duman Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression J. Neurosci. 22 2002 3251 3261
48. M.A. Smith, S. Makino, R. Kvetnansky, and R.M. Post Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus J. Neurosci. Off. J. Soc. Neurosci. 15 1995 1768 1777
49. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology (Berl) 85 1985 367 370
50. N. Tsankova, W. Renthal, A. Kumar, and E.J. Nestler Epigenetic regulation in psychiatric disorders Nat. Rev. Neurosci. 8 2007 355 367
51. N.M. Tsankova, O. Berton, W. Renthal, A. Kumar, R.L. Neve, and E.J. Nestler Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action Nat. Neurosci. 9 2006 519 525
52. C.G. Vecsey, J.D. Hawk, K.M. Lattal, J.M. Stein, S.A. Fabian, M.A. Attner, S.M. Cabrera, C.B. McDonough, P.K. Brindle, T. Abel, and M.A. Wood Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB: CBP-dependent transcriptional activation J. Neurosci. 27 2007 6128 6140
53. P. Willner, A. Towell, D. Sampson, S. Sophokleous, and R. Muscat Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant Psychopharmacology (Berl) 93 1987 358 364
54. C.A. Zarate Jr., J. Singh, and H.K. Manji Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder Biol. Psychiatry 59 2006 1006 1020